516 related articles for article (PubMed ID: 21749009)
1. Prevalence and resistance of Pseudomonas aeruginosa in severely burned patients: a 10-year retrospective study.
Lipový B; Rihová H; Hanslianová M; Gregorová N; Suchánek I; Brychta P
Acta Chir Plast; 2010; 52(2-4):39-43. PubMed ID: 21749009
[TBL] [Abstract][Full Text] [Related]
2. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R
Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175
[TBL] [Abstract][Full Text] [Related]
3. [Epidemiological profile and antibiotic susceptibility of Pseudomonas aeruginosa isolates within the burned patient hospitalized in the intensive care burn unit].
Lamia T; Bousselmi K; Saida BR; Allah MA
Tunis Med; 2007 Feb; 85(2):124-7. PubMed ID: 17665658
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Pseudomonas aeruginosa strains isolated from burned patients hospitalized in a major burn center in Tehran, Iran.
Ranjbar R; Owlia P; Saderi H; Mansouri S; Jonaidi-Jafari N; Izadi M; Farshad S; Arjomandzadegan M
Acta Med Iran; 2011; 49(10):675-9. PubMed ID: 22071644
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of distribution characteristics and drug resistance of 2748 strains of pathogens isolated from burn patients].
Peng DZ; Liu XL; Liu ZY; Shu WT; Zhou X; Liu J; Huang YS; Wu J; Fu WL
Zhonghua Shao Shang Za Zhi; 2012 Apr; 28(2):87-95. PubMed ID: 22781318
[TBL] [Abstract][Full Text] [Related]
6. The risk factors for acquisition of imipenem-resistant Pseudomonas aeruginosa in the burn unit.
Ozkurt Z; Ertek M; Erol S; Altoparlak U; Akcay MN
Burns; 2005 Nov; 31(7):870-3. PubMed ID: 15975720
[TBL] [Abstract][Full Text] [Related]
7. In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy.
Riou M; Carbonnelle S; Avrain L; Mesaros N; Pirnay JP; Bilocq F; De Vos D; Simon A; Piérard D; Jacobs F; Dediste A; Tulkens PM; Van Bambeke F; Glupczynski Y
Int J Antimicrob Agents; 2010 Dec; 36(6):513-22. PubMed ID: 20926262
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of the predominant bacterial strains on burn wound during early postburn stage].
Li TZ; Luo L; Xu YB; Deng XX; Liu S; Fan GY; Qi SH
Zhonghua Shao Shang Za Zhi; 2003 Apr; 19(2):71-4. PubMed ID: 12812628
[TBL] [Abstract][Full Text] [Related]
9. The impact of nosocomially-acquired resistant Pseudomonas aeruginosa infection in a burn unit.
Armour AD; Shankowsky HA; Swanson T; Lee J; Tredget EE
J Trauma; 2007 Jul; 63(1):164-71. PubMed ID: 17622885
[TBL] [Abstract][Full Text] [Related]
10. [Epidemiologic studies of the microbial colonization of severely burned patients].
Winkler M; Erbs G; Müller FE; König W
Zentralbl Bakteriol Mikrobiol Hyg B Umwelthyg Krankenhaushyg Arbeitshyg Prav Med; 1987 Jun; 184(3-4):304-20. PubMed ID: 3116791
[TBL] [Abstract][Full Text] [Related]
11. [Typical bacteria in an intensive care burn unit in severely burned patients and their importance with regard to mortality: retrospective study 1995 - 2004].
Steinsträsser L; Thies AH; Rabstein S; Steinau HU
Handchir Mikrochir Plast Chir; 2007 Oct; 39(5):338-44. PubMed ID: 17985278
[TBL] [Abstract][Full Text] [Related]
12. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
13. Imipenem-resistant Pseudomonas aeruginosa infection at a medical-surgical intensive care unit: risk factors and mortality.
Furtado GH; Bergamasco MD; Menezes FG; Marques D; Silva A; Perdiz LB; Wey SB; Medeiros EA
J Crit Care; 2009 Dec; 24(4):625.e9-14. PubMed ID: 19592213
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of multidrug-resistant organisms recovered at a military burn center.
Keen EF; Robinson BJ; Hospenthal DR; Aldous WK; Wolf SE; Chung KK; Murray CK
Burns; 2010 Sep; 36(6):819-25. PubMed ID: 20080354
[TBL] [Abstract][Full Text] [Related]
15. [Infective pathogens and drug resistance in burned patients].
Zhang X; Zhao BC
Hunan Yi Ke Da Xue Xue Bao; 2003 Aug; 28(4):405-8. PubMed ID: 14653131
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of hospitalized burn patients in a tertiary care hospital in South India.
Ganesamoni S; Kate V; Sadasivan J
Burns; 2010 May; 36(3):422-9. PubMed ID: 19782475
[TBL] [Abstract][Full Text] [Related]
17. Endocarditis in burn patients: clinical and diagnostic considerations.
Regules JA; Glasser JS; Wolf SE; Hospenthal DR; Murray CK
Burns; 2008 Aug; 34(5):610-6. PubMed ID: 18029099
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility and ESBL prevalence in Pseudomonas aeruginosa isolated from burn patients in the North West of Pakistan.
Ullah F; Malik SA; Ahmed J
Burns; 2009 Nov; 35(7):1020-5. PubMed ID: 19501980
[TBL] [Abstract][Full Text] [Related]
19. [Survey on the bacterial flora and their resistance to antibiotics in hospitalized burn patients on tropical islands].
Liang ZH; Pan YC; Chen SH; Xu JQ; Chen Y
Zhonghua Shao Shang Za Zhi; 2007 Apr; 23(2):88-90. PubMed ID: 17649878
[TBL] [Abstract][Full Text] [Related]
20. The time-related changes of antimicrobial resistance patterns and predominant bacterial profiles of burn wounds and body flora of burned patients.
Altoparlak U; Erol S; Akcay MN; Celebi F; Kadanali A
Burns; 2004 Nov; 30(7):660-4. PubMed ID: 15475138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
